• CDC42 Polarity Controls Intestinal Stem Cell Fate via YAP-mT

  2026-06-29

  The referenced study establishes that CDC42-mediated apical-basal polarity orchestrates the transition from intestinal stem cells to transit amplifying cells through a YAP-EGF-mTOR signaling cascade, independent of canonical Wnt signaling. These findings refine our mechanistic understanding of epithelial homeostasis and offer new avenues for investigating intestinal regeneration and disease.

• Protease Inhibitor Cocktail (EDTA-Free, 200X): Technical Use

  2026-06-29

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) is designed to prevent protein degradation during extraction and downstream analysis, especially when divalent cation compatibility is critical. It is recommended for workflows such as Western blotting, co-immunoprecipitation, and kinase assays, but should not be used in protocols requiring metalloprotease inhibition via EDTA or where DMSO sensitivity is a concern.

• Cardamomin Protects Neural Cells in Ischemic Stroke via NRF2

  2026-06-28

  Zhu et al. elucidate the neuroprotective mechanisms of cardamomin, a key chalcone from Amomum villosum, against oxidative damage in both in vitro and in vivo ischemic stroke models. Their findings highlight cardamomin’s modulation of the NRF2 pathway and inhibition of cell death processes, offering mechanistic insights for future neuroprotection strategies.

• Renal Blood Flow Modulation by K⁺ Channel Blockade in Sepsis

  2026-06-27

  This study probes how blocking specific potassium channels affects renal blood flow and vascular reactivity in septic rats exposed to vasoactive agents. The findings clarify the roles of ATP-sensitive and calcium-activated K⁺ channels in renal perfusion during sepsis, providing mechanistic insight relevant for vascular biology and sepsis research.

• Lipo3K Transfection Reagent: Redefining Lipid-Mediated Gene

  2026-06-26

  Explore how Lipo3K Transfection Reagent advances high-efficiency nucleic acid delivery, especially in challenging cell types. This in-depth article reveals novel mechanistic insights and practical strategies for gene expression and RNA interference research.

• Translating AR Heterogeneity into Actionable Prostate Cancer

  2026-06-26

  A thought-leadership perspective for translational researchers, integrating mechanistic insights on androgen receptor (AR) heterogeneity with strategic guidance for leveraging MDV3100 (Enzalutamide) in castration-resistant prostate cancer research. This article bridges cutting-edge evidence, protocol optimization, and future-facing experimental strategies, with a focus on actionable insights for the next generation of AR-pathway studies.

• SB 431542: Mechanistic Depth and Fibrosis Research Frontiers

  2026-06-25

  Explore the advanced use of SB 431542 as a potent ALK5 inhibitor for dissecting TGF-β signaling, with a unique focus on renal fibrosis models and Smad2/3 pathway analysis. This article provides mechanistic detail and strategic insights missing from standard protocol guides.

• Differential SHH and FGF Signaling in Penile Development Mod

  2026-06-25

  This study reveals that contrasting patterns of SHH, Fgf10, and Fgfr2 expression drive fundamental differences in prepuce and urethral groove formation between guinea pigs and mice. The findings challenge mouse-centric paradigms in congenital malformation research and provide new insight into human penile development.

• Angiotensin 1/2 (5-7): Reliable Solutions for RAS Research

  2026-06-24

  This article addresses practical laboratory challenges in renin-angiotensin system research and cell-based assays, highlighting how Angiotensin 1/2 (5-7) (SKU A1049) enables reproducible, data-driven experimentation. Drawing on recent literature and validated specifications, we evaluate its impact on assay consistency, protocol optimization, and vendor selection for cardiovascular and viral pathogenesis models.

• Ivermectin: Broad-Spectrum Anti-Parasitic Research Profile

  2026-06-23

  Ivermectin is a validated broad-spectrum anti-parasitic agent, widely used in parasitology research and drug development. Its mechanism targets parasite neuromuscular function, and APExBIO provides it at ≥97% purity for reproducible experimental use.

• Acifran: Driving Precision Lipid Metabolism Research Forward

  2026-06-23

  Acifran, a selective HM74A/GPR109A and GPR109B agonist, enables highly specific modulation of lipid signaling pathways for metabolic disorder research. Its structural clarity and reproducibility give researchers a distinct edge in designing translationally relevant lipid metabolism assays.

• K+ Channel Blockade Alters Renal Blood Flow in Septic Rats

  2026-06-22

  This study reveals that blocking ATP-sensitive and calcium-activated potassium channels in septic rats can exacerbate reductions in renal blood flow caused by norepinephrine and phenylephrine administration. These findings highlight critical considerations for vascular biology and sepsis research, particularly when using K+ channel modulators to probe vasoregulatory mechanisms.

• Bismuth Subsalicylate in GI Disorder Research: Protocols & T

  2026-06-22

  Bismuth Subsalicylate, a potent 1,3,2λ2-benzodioxabismin-4-one, transforms gastrointestinal disorder research with its robust inhibition of inflammation pathways and compatibility with membrane biology assays. This guide delivers stepwise protocols, experimental optimization, and troubleshooting tips for maximizing reproducibility and translational relevance.

• D-Luciferin Sodium Salt: Illuminating CAR-Macrophage Imaging

  2026-06-21

  D-Luciferin sodium salt is powering the next generation of ATP-dependent bioluminescence assays in oncology, enabling sensitive in vivo imaging of CAR-macrophage therapies. This article translates recent breakthroughs in CAR-M engineering into actionable protocols, troubleshooting strategies, and advanced applications for robust, non-invasive cellular monitoring.

• AZD6482: PI3Kβ Inhibitor Workflows for Platelet & Metabolic

  2026-06-20

  AZD6482 stands out as a highly selective PI3Kβ inhibitor, empowering advanced platelet aggregation and metabolic pathway studies with precise, reproducible results. This article highlights optimized experimental workflows, practical troubleshooting, and mechanistic insights—bridging cutting-edge screening science and translational research applications.

451 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page